Laboratory diagnosis and treatment of Mycoplasma pneumoniae infection in children: a review

References

• Krause DC, Leith DK, Wilson RM, et al. Identification of Mycoplasma pneumoniae proteins associated with hemadsorption and virulence. Infect Immun. 1982;35(3):809–817. doi: 10.1128/iai.35.3.809-817.1982.
   PubMedGoogle Scholar
• Chaudhry R, Ghosh A, Chandolia A. Pathogenesis of Mycoplasma pneumoniae: an update. Indian J Med Microbiol. 2016;34(1):7–16. doi: 10.4103/0255-0857.174112.
   PubMed Web of Science ®Google Scholar
• Waites KB, Crabb DM, Bing X, et al. In vitro suscep­tibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob Agents Chemother. 2003;47(1):161–165. doi: 10.1128/AAC.47.1.161-165.2003.
   PubMedGoogle Scholar
• Domingues D, Nogueira F, Tavira L, et al. Mycoplasmas: what is the role in human infections?. Acta Med Port. 2005;18(5):377–383.
   PubMedGoogle Scholar
• Waites KB. New concepts of Mycoplasma pneumoniae infections in children. Pediatr Pulmonol. 2003;36(4):267–278. doi: 10.1002/ppul.10346.
   PubMed Web of Science ®Google Scholar
• Kannan TR, Baseman JB. ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens. Proc Natl Acad Sci U S A. 2006;103(17):6724–6729. doi: 10.1073/pnas.0510644103.
   PubMed Web of Science ®Google Scholar
• Becker A, Kannan TR, Taylor AB, et al. Structure of CARDS toxin, a unique ADP-ribosylating and vacuolating cytotoxin from Mycoplasma pneumoniae. Proc Natl Acad Sci U S A. 2015;112(16):5165–5170. doi: 10.1073/pnas.1420308112.
   PubMed Web of Science ®Google Scholar
• Clyde WA.Jr. Clinical overview of typical Mycoplasma pneumoniae infections. Clin Infect Dis. 1993;17(Suppl 1): s 32–36.
   Google Scholar
• Song Z, Jia G, Luo G, et al. Global research trends of Mycoplasma pneumoniae pneumonia in children: a bibliometric analysis. Front Pediatr. 2023;11:1306234. doi: 10.3389/fped.2023.1306234.
   PubMedGoogle Scholar
• Narita M. Classification of extrapulmonary manifestations due to Mycoplasma pneumoniae infection on the basis of possible pathogenesis. Front Microbiol. 2016;7:23. doi: 10.3389/fmicb.2016.00023.
   PubMed Web of Science ®Google Scholar
• Lei W, Fei-Zhou Z, Jing C, et al. Pseudomembranous necrotizing laryngotracheobronchitis due to Mycoplasma pneumoniae: a case report and literature review. BMC Infect Dis. 2022;22(1):183. doi: 10.1186/s12879-022-07160-5.
   PubMed Web of Science ®Google Scholar
• Zeng XD, Chen H, Hu WG. Myelin oligodendrocyte glycoprotein (MOG) antibody-associated meningoencephalitis due to Mycoplasma pneumoniae infection. Neurol Res. 2023;45(2):124–126. doi: 10.1080/01616412.2022.2124794.
   PubMed Web of Science ®Google Scholar
• Grieb A, Kaderschabek N, Orasche C, et al. Mycoplasma pneumoniae-associated mucositis with cutaneous involvement - a case report. J Dtsch Dermatol Ges. 2019;17(2):184–185. doi: 10.1111/ddg.13714.
   Google Scholar
• Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53(7):e25–e76. doi: 10.1093/cid/cir531.
   Google Scholar
• Waites KB, Balish MF, Atkinson TP. New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections. Future Microbiol. 2008;3(6):635–648. doi: 10.2217/17460913.3.6.635.
   PubMed Web of Science ®Google Scholar
• Daxboeck F, Krause R, Wenisch C. Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin Microbiol Infect. 2003;9(4):263–273. doi: 10.1046/j.1469-0691.2003.00590.x.
   PubMed Web of Science ®Google Scholar
• Meyer Sauteur PM, Unger WWJ, van Rossum AMC, et al. The art and science of diagnosing Mycoplasma pneumoniae infection. Pediatr Infect Dis J. 2018;37(11):1192–1195. doi: 10.1097/INF.0000000000002171.
   PubMedGoogle Scholar
• Bernet C, Garret M, de Barbeyrac B, et al. Detection of Mycoplasma pneumoniae by using the polymerase chain reaction. J Clin Microbiol. 1989;27(11):2492–2496. doi: 10.1128/jcm.27.11.2492-2496.1989.
   PubMedGoogle Scholar
• Loens K, Ursi D, Goossens H, et al. Molecular diagnosis of Mycoplasma pneumoniae respiratory tract infections. J Clin Microbiol. 2003;41(11):4915–4923. doi: 10.1128/JCM.41.11.4915-4923.2003.
   PubMedGoogle Scholar
• Zhou J, Xiao F, Fu J, et al. Rapid, ultrasensitive and highly specific diagnosis of Mycoplasma pneumoniae by a CRISPR-based detection platform. Front Cell Infect Microbiol. 2023;13:1147142. doi: 10.3389/fcimb.2023.1147142.
   PubMedGoogle Scholar
• Loens K, Beck T, Ursi D, et al. Development of real-time multiplex nucleic acid sequence-based amplification for detection of Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Legionella spp. in respiratory specimens. J Clin Microbiol. 2008;46(1):185–191. doi: 10.1128/JCM.00447-07.
   PubMedGoogle Scholar
• Loens K, Beck T, Ursi D, et al. Evaluation of different nucleic acid amplification techniques for the detection of M. pneumoniae, C. pneumoniae and Legionella spp. in respiratory specimens from patients with community-acquired pneumonia. J Microbiol Methods. 2008;73(3):257–262. doi: 10.1016/j.mimet.2008.02.010.
   PubMedGoogle Scholar
• Stone BB, Cohen SP, Breton GL, et al. Detection of rRNA from four respiratory pathogens using an automated Q beta replicase assay. Mol Cell Probes. 1996;10(5):359–370. doi: 10.1006/mcpr.1996.0049.
   PubMedGoogle Scholar
• Kumar S. Mycoplasma pneumoniae: a significant but underrated pathogen in paediatric community-acquired lower respiratory tract infections. Indian J Med Res. 2018;147(1):23–31. doi: 10.4103/ijmr.IJMR_1582_16.
   PubMedGoogle Scholar
• Meyer Sauteur PM, Jacobs BC, Spuesens EB, et al. Antibody responses to Mycoplasma pneumoniae: role in pathogenesis and diagnosis of encephalitis? PLoS Pathog. 2014;10(6):e1003983. doi: 10.1371/journal.ppat.1003983.
   PubMedGoogle Scholar
• Watkins-Riedel T, Stanek G, Daxboeck F. Comparison of SeroMP IgA with four other commercial assays for serodiagnosis of Mycoplasma pneumoniae pneumonia. Diagn Microbiol Infect Dis. 2001;40(1–2):21–25. doi: 10.1016/s0732-8893(01)00250-4.
   PubMedGoogle Scholar
• Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17(4):697–728, table of contents. doi: 10.1128/CMR.17.4.697-728.2004.
   PubMed Web of Science ®Google Scholar
• Waris ME, Toikka P, Saarinen T, et al. Diagnosis of Mycoplasma pneumoniae pneumonia in children. J Clin Microbiol. 1998;36(11):3155–3159. doi: 10.1128/JCM.36.11.3155-3159.1998.
   PubMedGoogle Scholar
• Li W, Liu Y, Zhao Y, et al. Rapid diagnosis of Mycoplasma pneumoniae in children with pneumonia by an immuno-chromatographic antigen assay. Sci Rep. 2015;5(1):15539. doi: 10.1038/srep15539.
   PubMedGoogle Scholar
• Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372(9):835–845. doi: 10.1056/NEJMoa1405870.
   PubMed Web of Science ®Google Scholar
• Spuesens EB, Fraaij PL, Visser EG, et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med. 2013;10(5):e1001444. doi: 10.1371/journal.pmed.1001444.
   PubMed Web of Science ®Google Scholar
• Waites KB, Xiao L, Liu Y, et al. Mycoplasma pneumoniae from the respiratory tract and beyond. Clin Microbiol Rev. 2017;30(3):747–809. doi: 10.1128/CMR.00114-16.
   PubMed Web of Science ®Google Scholar
• García-González R, Costa-García A, Fernández-Abedul MT. Enzymatic amplification-free nucleic acid hybridisation sensing on nanostructured thick-film electrodes by using covalently attached methylene blue. Talanta. 2015;142:11–19. doi: 10.1016/j.talanta.2015.03.028.
   PubMedGoogle Scholar
• Henderson KC, Benitez AJ, Ratliff AE, et al. Specificity and strain-typing capabilities of nanorod array-surface enhanced Raman spectroscopy for Mycoplasma ­pneumoniae detection. PLoS One. 2015;10(6):e0131831. doi: 10.1371/journal.pone.0131831.
   PubMedGoogle Scholar
• Xue G, Li S, Zhao H, et al. Use of a rapid recombinase-aided amplification assay for Mycoplasma pneumoniae detection. BMC Infect Dis. 2020;20(1):79. doi: 10.1186/s12879-019-4750-4.
   PubMedGoogle Scholar
• Wang Y, Wang Y, Quan S, et al. Establishment and application of a multiple cross displacement amplification coupled with nanoparticle-based lateral flow biosensor assay for detection of Mycoplasma pneumoniae. Front Cell Infect Microbiol. 2019;9:325. doi: 10.3389/fcimb.2019.00325.
   PubMedGoogle Scholar
• Liu H, Lu Q, Hong J, et al. A systematic review of the therapy for Mycoplasma pneumoniae infections in children. Zhonghua Er Ke Za Zhi. 2016;54(2):111–118.
   PubMedGoogle Scholar
• Medjo B, Atanaskovic-Markovic M, Radic S, et al. Mycoplasma pneumoniae as a causative agent of community-acquired pneumonia in children: clinical features and laboratory diagnosis. Ital J Pediatr. 2014;40(1):104. doi: 10.1186/s13052-014-0104-4.
   PubMedGoogle Scholar
• China NHCotPsRo. Diagnosis and treatment guidelines for Mycoplasma pneumoniae pneumonia in children. Chin J Ration Drug Use. 2023;20(3):16–24.
   Google Scholar
• Lee KL, Lee CM, Yang TL, et al. Severe Mycoplasma pneumoniae pneumonia requiring intensive care in children, 2010–2019. J Formos Med Assoc. 2021;120(1 Pt 1):281–291. doi: 10.1016/j.jfma.2020.08.018.
   PubMed Web of Science ®Google Scholar
• Fang C, Mao Y, Jiang M, et al. Pediatric critical illness score, clinical characteristics and comprehensive treatment of children with severe Mycoplasma pneumoniae pneumonia. Front Surg. 2022;9:897550. doi: 10.3389/fsurg.2022.897550.
   PubMed Web of Science ®Google Scholar
• Li YT, Zhang J, Wang MZ, et al. Changes in coagulation markers in children with Mycoplasma pneumoniae pneumonia and their predictive value for Mycoplasma severity. Ital J Pediatr. 2023;49(1):143. doi: 10.1186/s13052-023-01545-1.
   PubMedGoogle Scholar
• Morozumi M, Takahashi T, Ubukata K. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother. 2010;16(2):78–86. doi: 10.1007/s10156-009-0021-4.
   PubMed Web of Science ®Google Scholar
• Tsai TA, Tsai CK, Kuo KC, et al. Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children. J Microbiol Immunol Infect. 2021;54(4):557–565. doi: 10.1016/j.jmii.2020.10.002.
   PubMedGoogle Scholar
• Lee H, Yun KW, Lee HJ, et al. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Expert Rev Anti Infect Ther. 2018;16(1):23–34. doi: 10.1080/14787210.2018.1414599.
   PubMed Web of Science ®Google Scholar
• Oishi T, Hattori N, Yoshioka D. Novel knowledge of macrolide resistance in Mycoplasma pneumoniae by azithromycin exposure. Microorganisms. 2024;12(1):218. doi: 10.3390/microorganisms12010218.
   PubMedGoogle Scholar
• Tanaka T, Oishi T, Miyata I, et al. Macrolide-resistant Mycoplasma pneumoniae infection, Japan, 2008–2015. Emerg Infect Dis. 2017;23(10):1703–1706. doi: 10.3201/eid2310.170106.
   PubMed Web of Science ®Google Scholar
• Sung M, Roh EJ, Lee ES, et al. Assessment of variables associated with prolonged admission duration in children with Mycoplasma pneumoniae pneumonia. Clin Respir J. 2022;16(11):756–767. doi: 10.1111/crj.13549.
   PubMedGoogle Scholar
• Charlotte Hsiung JC, Ma HY, Lu CY, et al. Children with Mycoplasma pneumoniae infection in Taiwan: changes in molecular characteristics and clinical outcomes. J Formos Med Assoc. 2022;121(11):2273–2280. doi: 10.1016/j.jfma.2022.05.001.
   PubMedGoogle Scholar
• Kimberlin DW. Red book pediatric infectious diseases clinical decision support chart. 3rd ed. Illinois (IL): American Academy of Pediatrics; 2024.
   Google Scholar
• Bradley Jdn JS, Barnett ED, Cantey JB, et al. 2024 Nelson’s pediatric antimicrobial therapy. 30th ed. Illinois (IL): American Academy of Pediatrics; 2024.
   Google Scholar
• Carris NW, Pardo J, Montero J, et al. Minocycline as a substitute for doxycycline in targeted scenarios: A systematic review. Open Forum Infect Dis. 2015;2(4):ofv178. doi: 10.1093/ofid/ofv178.
   PubMedGoogle Scholar
• Chen Y, Zhang Y, Tang QN, et al. Efficacy of doxycycline therapy for macrolide-resistant Mycoplasma pneumoniae pneumonia in children at different periods. Ital J Pediatr. 2024;50(1):38. doi: 10.1186/s13052-024-01615-y.
   PubMedGoogle Scholar
• Sánchez AR, Rogers RS, 3rd, Sheridan PJ. Tetracycline and other tetracycline-derivative staining of the teeth and oral cavity. Int J Dermatol. 2004;43(10):709–715. doi: 10.1111/j.1365-4632.2004.02108.x.
   PubMed Web of Science ®Google Scholar
• Ahn JG, Cho HK, Li D, et al. Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis. BMC Infect Dis. 2021;21(1):1003. doi: 10.1186/s12879-021-06508-7.
   PubMed Web of Science ®Google Scholar
• Miyashita N, Akaike H, Teranishi H, et al. Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacy. Antimicrob Agents Chemother. 2013;57(10):5181–5185. doi: 10.1128/AAC.00737-13.
   PubMed Web of Science ®Google Scholar
• Dai FF, Liu FQ, Chen X, et al. The treatment of macrolide-resistant Mycoplasma pneumoniae­pneumonia in children. J Clin Pharm Ther. 2021;46(3):705–710. doi: 10.1111/jcpt.13331.
   PubMedGoogle Scholar
• He YS, Yang M, Liu G, et al. Safety study of moxifloxacin in children with severe refractory Mycoplasma pneumoniae pneumonia. Pediatr Pulmonol. 2023;58(7):2017–2024. doi: 10.1002/ppul.26426.
   PubMedGoogle Scholar
• Cao B, Zhao CJ, Yin YD, et al. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis. 2010;51(2):189–194. doi: 10.1086/653535.
   PubMed Web of Science ®Google Scholar
• Yin YD, Cao B, Wang H, et al. Survey of macrolide resistance in Mycoplasma pneumoniae in adult patients with community-acquired pneumonia in Beijing, China. Zhonghua Jie He Hu Xi Za Zhi. 2013;36(12):954–958.
   PubMedGoogle Scholar
• Kawai Y, Miyashita N, Kubo M, et al. Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients. Antimicrob Agents Chemother. 2013;57(5):2252–2258. doi: 10.1128/AAC.00048-13.
   PubMed Web of Science ®Google Scholar
• Cao B, Qu JX, Yin YD, et al. Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance. Clin Respir J. 2017;11(4):419–429. doi: 10.1111/crj.12379.
   PubMed Web of Science ®Google Scholar
• Owens RC, Jr., Ambrose PG. Antimicrobial safety: focus on fluoroquinolones. Clin Infect Dis. 2005;41 Suppl 2:S144–S157. doi: 10.1086/428055.
   PubMed Web of Science ®Google Scholar
• Chen Y, Tian WM, Chen Q, et al. Clinical features and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Zhongguo Dang Dai Er Ke Za Zhi. 2018;20(8):629–634. doi: 10.7499/j.issn.1008-8830.2018.08.006.
   PubMedGoogle Scholar
• Chen L, Liu J, Zhao S, et al. Clinical features and treatment of refractory Mycoplasma pneumoniae pneumonia unresponded to conventional dose methylprednisolone in children. Zhonghua Er Ke Za Zhi. 2014;52(3):172–176.
   PubMedGoogle Scholar
• Liu J, He R, Zhang X, et al. Clinical features and “early” corticosteroid treatment outcome of pediatric Mycoplasma pneumoniae pneumonia. Front Cell Infect Microbiol. 2023;13:1135228. doi: 10.3389/fcimb.2023.1135228.
   PubMed Web of Science ®Google Scholar
• Lee YC, Chang CH, Lee WJ, et al. Altered chemokine profile in refractory Mycoplasma pneumoniae pneumonia infected children. J Microbiol Immunol Infect. 2021;54(4):673–679. doi: 10.1016/j.jmii.2020.03.030.
   PubMedGoogle Scholar
• Luo Z, Luo J, Liu E, et al. Effects of prednisolone on refractory Mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol. 2014;49(4):377–380. doi: 10.1002/ppul.22752.
   PubMed Web of Science ®Google Scholar
• Lan Y, Yang D, Chen Z, et al. Effectiveness of methylprednisolone in treatment of children with refractory Mycoplasma pneumoniae pneumonia and its relationship with bronchoalveolar lavage cytokine levels. Zhonghua Er Ke Za Zhi. 2015;53(10):779–783.
   PubMedGoogle Scholar
• Zhu Z, Zhang T, Guo W, et al. Clinical characteristics of refractory Mycoplasma pneumoniae pneumonia in children treated with glucocorticoid pulse therapy. BMC Infect Dis. 2021;21(1):126. doi: 10.1186/s12879-021-05830-4.
   PubMed Web of Science ®Google Scholar
• Chambert-Loir C, Ouachee M, Collins K, et al. Immediate relief of Mycoplasma pneumoniae encephalitis symptoms after intravenous immunoglobulin. Pediatr Neurol. 2009;41(5):375–377. doi: 10.1016/j.pediatrneurol.2009.05.008.
   PubMedGoogle Scholar
• Bian C, Li S, Huo S, et al. Association of atopy with disease severity in children with Mycoplasma pneumoniae pneumonia. Front Pediatr. 2023;11:1281479. doi: 10.3389/fped.2023.1281479.
   PubMedGoogle Scholar
• Pediatric Bronchoscopy Collaborative Group RG, Chinese Medical Association Pediatrics Branch. Guidelines for pediatirc brochoscopy. Chin J Pediatr. 2009;47(10):740–744.
   Google Scholar
• Wang Y, Liu K, Chen C, et al. Acetylcysteine and budesonide for the treatment of refractory Mycoplasma pneumoniae pneumonia in children: a clinical observation. Ital J Pediatr. 2023;49(1):80. doi: 10.1186/s13052-023-01491-y.
   PubMedGoogle Scholar
• Wang Chun K, See Wan Y, Poon Chuen W. Transient presence of lupus anticoagulant associated with mycoplasma pneumonia. Asian Cardiovasc Thorac Ann. 2016;24(3):286–287. doi: 10.1177/0218492315625158.
   PubMedGoogle Scholar
• Pachet A, Dumestre-Perard C, Moine M, et al. Splenic infarction associated with transient anti-prothrombin antibodies is a rare manifestation of acute Mycoplasma pneumoniae infection. Arch Pediatr. 2019;26(8):483–486. doi: 10.1016/j.arcped.2019.10.001.
   PubMedGoogle Scholar
• Kumaravel Kanagavelu AS, Nagumantry SK, Sagi SV, et al. A rare case of severe hemolytic anemia and pulmonary embolism secondary to Mycoplasma pneumoniae infection. J Med Cases. 2022;13(3):119–124. doi: 10.14740/jmc3866.
   PubMedGoogle Scholar
• Flateau C, Asfalou I, Deman AL, et al. Aortic thrombus and multiple embolisms during a Mycoplasma pneumoniae infection. Infection. 2013;41(4):867–873. doi: 10.1007/s15010-013-0475-2.
   PubMedGoogle Scholar
• Liu J, He R, Wu R, et al. Mycoplasma pneumoniae pneumonia associated thrombosis at Beijing Children’s hospital. BMC Infect Dis. 2020;20(1):51. doi: 10.1186/s12879-020-4774-9.
   PubMed Web of Science ®Google Scholar
• Huang X, Li D, Liu F, et al. Clinical significance of D-dimer levels in refractory Mycoplasma pneumoniae pneumonia. BMC Infect Dis. 2021;21(1):14. doi: 10.1186/s12879-020-05700-5.
   PubMed Web of Science ®Google Scholar